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Abstract
Background: Metofluthrin reduces biting activity in Aedes aegypti through the confusion, knockdown, and
subsequent kill of a mosquito. A geographical spread in dengue, chikungunya, and Zika viruses, increases
intervention demands. Response to a Zika outbreak may require a different strategy than dengue, as high-risk
individuals, specifically pregnant women, need to be targeted.
Methods: In semi-field conditions within a residential property in Cairns, Queensland, the impacts of metofluthrin
on biting behaviour of free-flying Wolbachia-infected Ae. aegypti were evaluated.
Results: Mortality in Ae. aegypti exposed to metofluthrin over a 22 h period was 100% compared to 2.7% in an
untreated room. No biting activity was observed in mosquitoes up to 5 m from the emanator after 10 min of
metofluthrin exposure. Use of metofluthrin reduced biting activity up to 8 m, regardless of the host’s proximity
(near or far) to a dark harbourage area (HA) (P < 0.0001 and P = 0.006), respectively. In the presence or absence of
the metofluthrin emanator, the host was most likely bitten when located immediately next to a HA (within 1 m)
versus 8 m away from the HA (P = 0.006). The addition of a ceiling fan (0.8 m/s airflow) prevented all biting activity
after 10 min of metofluthrin exposure. Previously unexposed Ae. aegypti were less likely to reach the host in a
metofluthrin-treated room X

= 31%) compared to an untreated room (X ¼ 100%) (P < 0.0001). In a treated room,
if the mosquito had not reached the host within 30 s, they never would. Upon activation, the time required for
metofluthrin to infiltrate protected locations within a room causing knockdown in caged mosquitoes, required more
time than exposed locations (P < 0.003); however exposed and protected locations do eventually reach equilibrium,
affecting mosquitoes equally throughout the room.
Conclusion: Metofluthrin is effective in interrupting indoor host-seeking in Ae. aegypti. Metofluthrin’s efficacy is
increased by centrally locating the emanator in the room, and by using a fan to increase airflow. Newly treated
rooms may require a period of 2–4 h for sufficient distribution of the metofluthrin into protected locations where
mosquitoes may be resting.
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Background
Aedes aegypti (L.) has a ubiquitous distribution through-
out urban areas in tropical regions of the world and is
the primary vector of dengue (DENV), yellow fever
(YFV), chikungunya (CHKV), and Zika (ZIKV) viruses
[1–3]. In the last 50 years, the public health impact of
DENV and CHKV has increased dramatically, with both
diseases spreading geographically and increasing in inci-
dence [4]. Recently, ZIKV has had major impacts on
public health, particularly in South America, with in-
creasing incidence of imported and locally acquired
cases occurring globally [5, 6]. Countries with confirmed
mosquito transmission of ZIKV have so far been limited
to South and Central America, the Pacific Islands,
including Papua New Guinea, and most recently in the
southern United States, in Miami Florida [7].
In Australia, Ae. aegypti’s current distribution is lim-
ited to Queensland [8] and is most abundant in the far
north where outbreaks of DENV occur regularly as a re-
sult of imported cases [9–11]. Since 2011, 1842 cases of
DENV, and 49 cases of CHKV have been reported, and
37 cases of ZIKV since 2015 [12]. Local transmission of
both CHKV and ZIKV have yet to be observed, however
regular outbreaks of DENV, illustrate the potential for
outbreaks of both of these viruses.
Studies have shown reduced vector competence in Ae.
aegypti infected with the wMel strain of Wolbachia for
DENV, CHKV, and YFV [13, 14]. More recent evidence
also shows reduced vector competence in a Colombian
strain of wMel Ae. aegypti using ZIKV-infected mice
[15]. In parts of far north Queensland, a project involv-
ing the release of wMel-infected Ae. aegypti is underway,
whereby wMel-infected male and female Ae. aegypti are
released in large numbers to replace the wild population
[16]. If successful, local transmission of DENV in
Australia, could be significantly reduced. However, it
should be noted that high densities of Ae. aegypti with
poor vector competence, have successfully sustained
arbovirus outbreaks in the past, as seen with YFV [17].
Indoor residual spraying (IRS) remains the current
best practice in limiting DENV outbreaks [9]. It is
labour-intensive, and in Queensland, is usually limited to
viraemic contact addresses, their nearest neighbours,
and other identified high-risk properties (i.e. hostels) [9,
18]. It is also limited by whether or not the house owner
grants permission to enter the premises [18], and in an
outbreak, labour resources to apply IRS can become rap-
idly exhausted, leaving large parts of the population vul-
nerable for periods of time. Currently, Queensland
homeowners are encouraged to use commercially avail-
able repellents and indoor surface sprays both during
and outside an outbreak, to control DENV vectors [19].
However, acceptance, compliance, and efficient use of
this method will vary between individuals. Targeted
indoor residual spraying for DENV control works on the
principal that adult Ae. aegypti are endophilic and are
highly attracted to dark objects and shady areas. Treat-
ment of these areas with residual insecticides can kill
adult mosquitoes seeking to rest on treated surfaces,
interrupting transmission [9, 20].
There is a gap in this method that needs to be ad-
dressed, and that is, “how do we protect an uninfected
person from being bitten by an infected mosquito that
newly enters a dwelling?” This question becomes par-
ticularly important with the global emergence of ZIKV
and protecting pregnant women from infective bites.
The response during a ZIKV outbreak may, in fact, look
quite different from the strategies that would be applied
to DENV. In addition to high-risk properties, high-risk
individuals (e.g. pregnant women) will also need to be
targeted, making interventions such as widespread IRS
difficult to employ. This is where alternative strategies
that are highly effective, safe, commercially available, in-
expensive, easy to use, and receive wide public accept-
ance, become very important.
Commercially available spatial repellents, such as mos-
quito coils and vaporizer mats are well documented in
repelling mosquitoes from human biting [21, 22]. Unfortu-
nately, both of these products are limited by their degree of
efficacy, the requirement for a heat source to vaporize their
active ingredient [22, 23], and their limited use indoors [24].
Studies have shown varying susceptibility to pyrethroid-
based mosquito coils between different mosquito species,
and within a species, specifically Ae. aegypti [22, 23]. A study
by Liu et al. [25] found a large suite of volatile organic com-
pounds, including carcinogens and suspected carcinogens in
the mosquito coil smoke. In fact, mosquito coil smoke pro-
duced the same amount of fine and ultrafine particulate
matter mass as burning 75–137 cigarettes [25]. Recently, a
study in Ghana found mosquito coils had little effect on
reducing malaria incidence. They did, however, present a
potential respiratory risk factor that requires further investi-
gation [26]. The need for safer, more effective, inexpensive,
and simple, spatial repellents remains.
Investigations into the insecticidal activity of nonchry-
santhemic acid esters with high vapour activity at ambi-
ent temperature [27] have resulted in the development
of a synthetic pyrethroid commonly known as metoflu-
thrin. Metofluthrin is a volatile pyrethroid insecticide
that has been shown to be extremely effective in redu-
cing biting in Ae. aegypti [28–30]. The efficacy of this
compound lies in its safe and effective use indoors; it
accumulates within a room rapidly and affects biting
activity within a relatively short period of time [31].
Often referred to as a “spatial repellent,” its mode of ac-
tion is not through repellency at all, but rather through
the disruption in orientation towards the host (prevent-
ing biting), knockdown, and kill of Ae. aegypti [21, 31].
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In this study, we investigated the use of a 10% active
ingredient (AI) metofluthrin emanator (Sumitomo
Chemical Australia Pty Ltd) indoors by determining: its
effective range and impacts on mosquito biting and mor-
tality; its efficacy against new mosquitoes entering a
treated room; and the potential for protection of mos-
quitoes resting in cryptic harbouring areas within a
treated room. Based on metofluthrin studies to date, this
product may provide a complimentary solution to fill
the current gaps in handling arbovirus outbreaks trans-
mitted by Ae. aegypti, by interrupting disease transmis-
sion to the most vulnerable.
Methods
Experimental setting
All experiments took place within a large enclosed living
area (111 m3) below a typical Queenslander-style house
in Cairns, Queensland, Australia (Fig. 1a–d). Through-
out this study we will use the term “harbourage area”
(HA) to describe an object, usually a suitcase, that is
black or dark surfaced. Since Ae. aegypti have a tendency
to gather and rest near, and on dark surfaces, we use
these HAs to visually bait or direct the mosquito to a
chosen part or parts of the room throughout this study.
The metofluthrin product used in this study was a small
(9.5 × 15 × 1 cm), plastic frame containing a polyethylene
mesh which the 10% AI w/w formulation is incorporated
into (Sumitomo Chemical Australia Pty Ltd., Sydney,
Australia) [31] (Fig. 2a). In previous longevity studies of this
emanator, its efficacy was sustained up to 20 days [31].
Rearing, sexing, caging and blood-feeding mosquitoes
A Cairns colony (F1) of Ae. aegypti infected with wMelWol-
bachia, derived from field populations, was used throughout
the experiments. The colony was reared in a controlled
temperature room at 25 °C and maintained at 70% relative
humidity. Wolbachia-infected mosquitoes were used to
avoid accidental introduction of uninfected mosquitoes in
an area where the Eliminate Dengue program had estab-
lished wMel in Ae. aegypti. Female mosquitoes were sepa-
rated as pupae by size and then allowed to emerge into
500 ml containers or into a BugDorm (30 × 30 × 30 cm),
depending on the requirements of the experiment. A 10%
honey pad was provided and removed 24 h prior to use in
experiments. During rearing, when blood meals were re-
quired, mosquitoes were offered a blood meal by resting the
back of a human leg on top of the cage or container.
Human landing counts
During experiments where a human landing count
(HLC) was performed, the lower half of both legs were
exposed, and only landing/biting attempts on the
exposed lower legs were recorded.
Twenty-two-hour exposure: recovery and survival (fan off)
To observe the impact of metofluthrin on Ae. aegypti
survival, forty female Ae. aegypti were released into a
Fig. 1 a Floor plan of the large experimental room (111 m3). b-d 360-degree view of the large experimental room
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large room (111 m3) (Fig. 1) for a 22-h period in both a
metofluthrin-treated and an untreated room. An initial
HLC was performed immediately prior to each
treatment and replication to confirm the fitness of the
released mosquitoes. During the treatment replications,
the metofluthrin emanator was activated by removing
the emanator from the packaging and placing it in cen-
trally within the room to volatilize immediately following
the pre-treatment HLC. After 22 h, all live mosquitoes
were collected from the room using an insect net, and
all knocked down mosquitoes were gently collected into
paper towel-lined 500 ml cups using forceps. Observa-
tions for mortality and recovery occurred up to 3 h after
the completion of each replication. A total of 5 replica-
tions were completed. Data from the experiment were
analyzed using a Mann-Whitney test in Prism 6.
Effective spatial range of metofluthrin (fan off)
In a large room (111 m3) with four HAs placed in each
corner of the room, and a centrally located metofluthrin
emanator (Fig. 2d), 10 female Ae. aegypti were released
for each replicate, and biting activity was observed over
a 5-min period each at 1, 3 and 5 m intervals from the
emanator. Once the mosquitoes were released, they were
allowed to settle over a 10-min period. For each replica-
tion, a control was performed prior to the treatment.
For the treatment, the metofluthrin emanator was
activated for 10 min prior to the first HLC. A total of 4
replications were completed. Between each replicate, the
room was aired out using strong fans with all windows
and doors open over a 2-h period. Mosquitoes were not
removed or replaced when rotating through the three lo-
cations (1, 3 and 5 m) in the room, however, the starting
point for each replication was rotated. Data were
analyzed using a Mann-Whitney test in Prism 6.
The effect of host and metofluthrin location relative to
harbourage areas on human landing counts (fan on vs
fan off)
Fan off
Here we visually baited female Ae. aegypti with one large
HA, at one end of the room (Fig. 3a, b). We looked at
the influence of the proximity of the host and the meto-
fluthrin emanator to HAs on HLCs. In order to do this,
we performed two treatments: (i) when the host was
near, this meant that the host was within 1 m of the
HA, and the emanator was placed on the opposite end
of the room, 8 m away from the HA and the host; (ii)
when the host was far from the HA, the host would be
8 m from the HA on the opposite end of the room, and
the emanator located immediately next to the HA. Dur-
ing the control replicates for each of these treatments,
near and far refer to the position of the host relative to
Fig. 2 a 10% AI metofluthrin emanator (Sumitomo). b Mean (± SE) human landing count before and after control and treatment (METO+)
groups. c The mean (± SE) number of mosquitoes recollected after 22 h, and the mean (± SE) survival (%) of recollected mosquitoes. d
Experimental room set-up indicating locations of HLCs, the metofluthrin emanator, and the harbourage sites. e Mean (± SE) human landing
counts at 1, 3 and 5 m proximity to the emanator
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the HA without the presence of an active emanator in
the room.
For each replication, 10 Ae. aegypti females were re-
leased into the room (111 m3) and allowed to settle for
10 min. A 5-min HLC was performed prior to each
treatment (activation of the metofluthrin emanator in
the room), as a control, corresponding to the host loca-
tion (near or far) of the subsequent treatment. Once the
control was completed, the mosquitoes were again
allowed 5 min to settle prior to activating the metoflu-
thrin emanator. The metofluthrin, once activated, was
allowed to volatilize for 10 min prior to the HLC. A total
of 14 replications were performed. Halfway through the
replications, the HAs were moved to the opposite end of
the room to eliminate a location effect. Data were
analyzed in SPSS using a negative binomial regression
analysis.
Fan on
In a related experiment, we repeated the above protocols
with the addition of a ceiling fan. We wanted to see if a
ceiling fan on its lowest setting (0.8 m/s airflow when
standing directly below the fan, measured with a Kestrel
anemometer, 1000 model) would aid in the circulation
of the metofluthrin throughout the room, thus increas-
ing its efficacy against host-seeking Ae. aegypti. A total
of 4 replications were completed. Data were analyzed in
Prism 6 using a Mann-Whitney test.
Introduction of a new mosquito to a treated room (fan off)
In a 70 m3 bedroom, attached to the large main room
(Fig. 4a, b), one female Ae. aegypti was released for each
replication of the control (n = 16) and treatment
(n = 16). For the treatment, a metofluthrin emanator
was allowed to volatilize centrally within the room
(without a fan) for a 30-min period (Fig. 4a, b). Each
mosquito was released from a small covered (200 ml) cy-
lindrical container at the corner of the room, approxi-
mately 3 m from the host (Fig. 4a, b). The host sat
centrally in the room, at the end of the bed, next to the
activated emanator (Fig. 4a, b). The time required for
the mosquito to reach the host was recorded, for up to
10 min, for both the control and treatment. Whether or
not the mosquito reached the host was also recorded. A
total of 16 replications were completed. Data were ana-
lyzed in Prism 6 using a Fisher’s exact test.
Impact of protected mosquito resting areas on efficacy
(fan on)
Groups of five female Ae. aegypti were placed into
separate tambourine cages (Fig. 5b) and placed in se-
lected exposed and protected locations within a large
room (Fig. 5a-d). Exposed locations were in plain
sight and unsheltered, where protected locations were
sheltered within the room (e.g. under a bed or behind
an object leaning against a wall).
Fig. 3 a Room set-up for metofluthrin “far” from the HA and host “near,” where “H” indicates clusters of harbourage items and “M” indicates the loca-
tion of the metofluthrin. b Room set-up for metofluthrin “near” the HA and host “far.” c HLCs (± SE) with the fan off. d HLCs (± SE) with the fan on
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Fig. 4 a Bedroom set-up (70 m3). “R” indicates the mosquito release point. Metofluthrin emanator indicated by “M,” next to the host. b Photo of
bedroom set-up. c Containers individual mosquitoes were held in and released from. d Mean percent (± SE) of Ae. aegypti released that reached
the host within 10 min. In the treatment group, 31.3% of all mosquitoes reached the host. e Of all mosquitoes that reached the host post-release,
the mean (± SE) number of seconds required
Fig. 5 a Room set-up indicating protected and exposed locations within the room where tambourine cages of female Ae. aegypti were placed. “P”
and “E” refer to protected and exposed locations, respectively. P-1 = behind large painting leaning against wall; P-2 = under the bed; and P-3 =
inside the cupboard with door ajar; E-3 m = exposed 3 m from emanator; and E-5 m = exposed 5 m from the emanator. “M” indicates the location
of the metofluthrin emanator. b Tambourine cage. c-d View of experimental set-up within the room indicating protected and exposed locations
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Three protected locations were created within the room:
(i) behind a large painting leaning against a wall (Fig. 6a);
(ii) underneath a bed (Fig. 6b), and (iii) within a cupboard
with its door 5 cm ajar (Fig. 6c). Two exposed locations
were also included at 3 and 5 m distance from the emana-
tor (Fig. 5a, c). Five female Ae. aegypti were kept in a tam-
bourine cage in a separate untreated room as a control.
Once in position, the metofluthrin emanator was activated
in the room, and the time to 100% knockdown was re-
corded. One hundred percent knockdown was used as the
indicator that the replication for the treatment (protected
or exposed) was completed.
A ceiling fan on low setting (0.8 m/s) was used to aid in
air circulation of the volatilizing compound. Using a flash-
light, cages were visually assessed for knockdown every
15 min in order not to disrupt the tambourine cage or con-
taminate the airspace surrounding it. Once 100% of the
mosquitoes were knocked down within a cage, it was im-
mediately replaced with another cage of 5 mosquitoes, tak-
ing care not to disturb the protected space or expose the
second cage prior to its placement. The second cage was
observed every 15 min until 100% KD was achieved, and
then removed. Between each replication, the bed and paint-
ing were moved and turned over, and the cupboard opened
widely, to ensure the metofluthrin was evacuated from the
protected spaces properly. Fans were turned on high and all
doors and windows open for 2 h. A total of 5 replications
were completed. The time to achieve 100% knockdown was
compared between the protected and exposed locations for
both the first and second exposure of tambourine cages.
The second exposure allowed us to observe whether or not
knockdown in the protected locations, over time, would be
a result of a maintained low-dose exposure or if the con-
centration of the compound in the protected space would
reach some level of equilibrium with the rest of the room.
Five mosquitoes in a tambourine cage were kept in a separ-
ate room, outside of the treatment area as a control for
each replicate. Data were analyzed using a negative bino-
mial regression analysis in SPSS.
Statistical analysis
Data were analyzed, depending on the model required
for each analysis, in IBM® SPSS® version 24.0 or Prism 6
for Mac OSX (v. 6.0 h, GraphPad Software Inc.).
Results
Preliminary study: 22-h survival (fan off)
One hundred percent mortality was observed in Ae.
aegypti exposed to a 10% AI metofluthrin emanator over
a 22-h period in a largely treated room versus 2.7% mor-
tality in the untreated room, indicating the high impact
on mosquito mortality as a result of exposure to the
Fig. 6 a The painting (P-1) leaning against wall with a tambourine cage behind it. b Tambourine cage location under the bed (P-2). c Cupboard ajar
(P-3) containing tambourine cage. d Mean number of minutes (95% CIs) required for 100% KD to be achieved in each tambourine cage between
locations in the first exposure. E-3 m and E-5 m: exposed cages at 3 and 5 m distance from the emanator, respectively; P-1: behind painting; P-2:
under bed; P-3: in the cupboard with the door ajar. e Difference in the mean (95% CIs) number of minutes to 100% knockdown of mosquitoes
between exposed and protected locations and the first and second exposure
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metofluthrin emanator over a sustained period (U = 0,
P = 0.0079),. The mean of the initial HLCs performed over
a 5-min period prior to each control or treatment replica-
tion, were 81.4 and 70, respectively, confirming similar
levels of activity and fitness of the mosquitoes used in
both the treatment and control replications. (Fig. 2b, c).
Effective spatial range of metofluthrin (fan off)
After a 10-min exposure period to the metofluthrin
emanator, irrespective of the host’s distance from the
metofluthrin emanator (1, 3 and 5 m), all mosquito
host-seeking behaviour ceased in the presence of meto-
fluthrin. A Mann-Whitney test found that the metoflu-
thrin significantly impacted the host-seeking activity of
the mosquitoes (U = 0, P < 0.0001). Host-seeking activity
was observed during the control replicates, as indicated
by the high values of HLCs taken over a 5-min period
(Fig. 2e).
The effect of host and metofluthrin location relative to
harbourage areas on human landing counts (fan on vs
fan off)
Fan off
A negative binomial regression analysis found that both
the treatment (presence or absence of the metofluthrin)
and the location of the host (near or far from the HA)
were significant predictors of HLCs (P < 0.0001 and
P = 0.006, respectively); however, an interaction between
host location and treatment was not found. Biting activ-
ity, overall, was reduced by 78% in the presence of a 10%
AI metofluthrin emanator, and the host was most likely
to be bitten, regardless of the presence or absence of the
metofluthrin, when located near the HA (within 1 m),
opposed to being located far from the HA (8 m away),
on the opposite end of the room (Fig. 3c). In the
presence of an active emanator, host-seeking behaviour,
although reduced, was detectable at 10 and 20 min post-
activation with the fans off.
Fan on
When the same experiment (Fan off ) was repeated with
a ceiling fan on “low” setting (0.8 m/s airflow when
standing directly below fan), mosquito host-seeking be-
haviour was reduced by 100% (U = 0, P < 0.0001) when
a metofluthrin emanator was present in the room,
regardless of its location in the room (Fig. 3d). In the
absence of the metofluthrin emanator, the host was most
likely to be bitten when located near the HA (within
1 m) (Fig. 3d).
Introduction of a new mosquito to a treated room (fan off)
A Fisher’s exact test found that when mosquitoes were
released into a treated room, they were less likely to find
the host compared to mosquitoes released into an
untreated room (P < 0.0001), X ¼ 31:25% and 100%,
respectively (Fig. 4d). We also found that 100% of mos-
quitoes within the room reached the host in 76 s
(n = 15), on average, and 26 s in a treated room (n = 5)
(Fig. 4e). During the treatment, if the mosquito hadn’t
found the host within the first 35 s of entering the room,
it was unlikely to ever reach the host and attempt blood
feeding.
The impact of protected mosquito resting areas on
efficacy (fan on)
Using a negative binomial regression analysis, a signifi-
cant effect of exposure type was found on mosquito
knockdown in exposed versus protected locations
(P = 0.003). Overall, cages of mosquitoes in exposed lo-
cations of the room reached 100% knockdown at a sig-
nificantly faster rate than those placed in protected
locations, X = 23.96 min and X = 57.6 min, respectively
(Fig. 6d). Exposure round, whether or not the cage of
mosquitoes was the first or second cage at each location,
was also a significant predictor in the time required to
achieve 100% knockdown (P = 0.004), regardless of
whether or not it was exposed or protected. The second
cage placed at any location achieved 100% knockdown
more rapidly than the first cage placed at the same loca-
tion, X = 55.96 min and X = 24.66 min, respectively
(Fig. 6e). A significant interaction was also observed be-
tween the two independent variables, exposure type and
exposure round (P < 0.0001). Upon activation, the time
required for metofluthrin to infiltrate protected resting
locations within a room causing knockdown in caged
mosquitoes, required more time than the exposed loca-
tions, X ¼ 94 min and X = 31.5 min, respectively. In the
second exposure round, the mean time required to
achieve 100% knockdown in protected versus exposed
locations was 35.5 mins and 18.8 mins, respectively, in-
dicating an increase in the accumulation and infiltration
of metofluthrin within the room and to the protected lo-
cations (Fig. 6e). The 5 control cages located in a separ-
ate untreated room maintained 0% KD throughout the
duration of the experiment.
Discussion
When an individual is particularly vulnerable during an
arbovirus outbreak (e.g. pregnant women and ZIKV),
they are dependent upon the effective implementation of
vector control at all levels, including government and
community. At the individual level, it is important that
safe and effective products are accessible commercially
as it allows the individual to take control over their own
health, including their families.
From previous studies, we understand that metoflu-
thrin has two main modes of action in reducing human
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biting: firstly, through confusion and disruption in orien-
tation towards the host that stops biting; and secondly,
through the knockdown and subsequent kill of the mos-
quito [21, 28, 31]. Here we explored the use of metoflu-
thrin 10% AI in the household in order to better
understand how to use this product within the home to
protect the individual. It is important to note that the
size of the rooms (111 m3 and 70 m3) that we used in
these experiments were much larger than the rooms
(approx. 25 m3) used in previous metofluthrin studies by
Rapley et al. [21] and Ritchie & Devine [31].
The insecticidal properties of the metofluthrin on Ae.
aegypti were confirmed here over a 22-h exposure
period where we observed 100% mortality, similar to
what was found by Rapley et al. [21] with a 4.1% AI
emanator in a 25 m3 room. Without the assistance of a
fan, when the metofluthrin emanator was centrally lo-
cated within a large room, all biting ceased after 10 min
of exposure within 5 m of the emanator. Earlier studies
in a 25 m3 room found negligible biting after 8 min of
exposure to a 10% AI metofluthrin emanator [31]. Given
the size of our room, we had expected the mosquitoes to
escape the effective range of the emanator, and for host-
seeking activity to continue much longer than the 8 min
observed by Ritchie et al. [31] in a 25 m3 room with a
10% AI formulation. A more recent study by Darbro et
al. [32] using bioassay cages and hand landing counts in
indoor spaces, found that irrespective of room size, after
10 min of exposure, landing rates were reduced by 50–
90% and 25–90% at 1 m and 3 m, respectively. A result
which also supports host-seeking activity in the presence
of the metofluthrin emanator after 10 min. An extended
observation in the same study found that in a 42 m3
room, probing behaviour continued at one meter from
the emanator up to 6 h, and up to 53 h when the cage
was set at three meters away. Based on the results of
Darbro et al. one would assume that in our 111 m3
room, that some host-seeking activity would have per-
sisted past 10 min, however, this was not the case. The
results from Darbro et al. tend to underestimate the true
efficacy of the 10% AI metofluthrin emanator with free-
flying mosquitoes indoors. This could be explained by a
decrease in airflow into bioassay cages, and therefore a
subsequent delay in the effect of the metofluthrin on the
mosquitoes.
When we discovered that the effective range of the
metofluthrin was greater than we initially anticipated
based on previous studies, we needed to increase the
range of the emanator, Within the constraints of our
large room, we were able to increase this range to eight
meters. Here we used an HA to visually “bait” the mos-
quito to one end of the room while placing the metoflu-
thrin emanator or host immediately next to or opposite
it (eight meters), and always opposite each other. The
HA encouraged harbouring of the mosquitoes immedi-
ately next to or opposite (eight meters distance) the
emanator. With the fans off, host-seeking behaviour was
reduced overall by 78% after 10 min of metofluthrin ex-
posure, regardless of the location of the emanator or the
host relative to the HA. A negligible level of host-
seeking continued up to 20 min post-activation of the
emanator. When we repeated the experiment with a ceil-
ing fan (0.8 m/s), at 10 min post activation, all biting
had ceased, illustrating the importance of air circulation
when using metofluthrin in large spaces.
When we look at the primary gap that metofluthrin
could fill when it comes to controlling vector-borne dis-
eases transmitted by Ae. aegypti, it’s the protection of in-
dividuals from the bites of host-seeking Ae. aegypti that
have newly entered a dwelling. For example, indoor re-
sidual spraying targets mosquito resting areas not flying
mosquitoes that have newly entered a dwelling or room
seeking a host. In this study, we found that previously
unexposed mosquitoes released into a metofluthrin-
treated room had a 31% frequency of reaching the host
without seeking a resting site first, versus 100% success
in reaching the host during the control. Of that 31.25%,
we discovered that if the mosquito did not reach the
host within 30 s of entering a treated room, they were
unlikely ever to reach the host. The distance between
the released mosquito and the host seated on the bed
was approximately three meters within a completely
white room with very few visual distractions, making it
less challenging for the mosquito to find the host. While
there is some risk of biting from quick entry, the room
is essentially protected.
This brought us to ask the next question: is there any-
where within a treated room that a mosquito can remain
protected from the effects of the metofluthrin, whereby
at any time it could leave its small “pocket of protection”
nearby a host, and attempt blood feeding? Within a
household, there are objects, ranging from a bookshelf
to a basket of laundry, and regardless of whether or not
these items are organized or cluttered, they provide har-
bouring areas for Ae. aegypti in the home. We created
three protected HAs that were common and where a
mosquito could potentially reduce its exposure to meto-
fluthrin in the home: behind an object leaning against a
wall; under a bed; and within a cupboard that had its
door slightly ajar. When we placed Ae. aegypti into these
protected spaces and compared them to mosquitoes that
were in exposed positions, we found that from the time
of metofluthrin activation, there was a significant delay
in effect between the protected mosquitoes and the ex-
posed, indicating a potential lapse in protection. On
average, the exposed and protected groups achieved
100% knockdown within 31 and 94 min, respectively,
after activation of the metofluthrin. This suggests that
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mosquitoes in protected spaces took three times longer
to receive the impacts of the metofluthrin from the time
the emanator was activated. In the second exposure to
the same emanator, the respective mean time to knock-
down was shortened to 18 and 35 min for exposed and
protected mosquitoes. This illustrates that there is a
delay for these protected spaces to become infiltrated
with metofluthrin, and in time the exposed and protected
spaces will reach equilibrium, affecting mosquitoes
equally throughout the room in terms of impacts on
host-seeking and mortality.
The next stage of these metofluthrin studies is to in-
vestigate the efficacy of these devices on free-flying Ae.
aegypti in the common areas around the house that are
covered, but essentially outdoors (e.g. verandas) as well
as rooms with open windows and airflow. An earlier
study by Kawada et al. [33] in Vietnam found that a de-
crease in openings to a room treated with metofluthrin-
impregnated plastic strips positively affected the spatial
repellency of the metofluthrin. On a veranda setting in
north Queensland, using a bioassay cage containing Ae.
aegypti, a significant reduction in biting activity was ob-
served at one meter from the metofluthrin emanator
[32] and in outdoor field trials in the U.S., metofluthrin-
impregnated paper emanators reduced biting in Aedes
vexans between 95 and 97% when located at 1.2 m from
the host [30]. These studies support and highlight the
need for further field trials on the effects of metofluthrin
on Ae. aegypti in semi-outdoor areas as well as indoor
rooms with open doors and windows.
Conclusions
Metofluthrin is very effective in interrupting the host-
seeking abilities of female Ae. aegypti within a short
period of time and over an extensive area indoors. In fu-
ture outbreaks of viruses transmitted by Ae. aegypti,
metofluthrin may play an important role in personal
protection and disease control, particularly in instances
where large-scale operations are exhausted, and vulner-
able individuals need to be targeted.
Within the limits of this study, we have been able to
describe the strengths and limitations of this novel com-
pound. From this, several recommendations for use are
apparent. First, without fans, metofluthrin works very
well, however, in these instances, it is important that the
emanator remains centrally located within a room.
Secondly, to increase efficacy, particularly when looking
at covering larger spaces, metofluthrin is most efficiently
distributed with the aid of a fan. Thirdly, when newly
treating a room with metofluthrin, it is best to allow a
period of 2–4 h of exposure to ensure a sufficient distri-
bution of the compound throughout the room and to its
protected or sheltered areas within it where mosquitoes
may be resting.
Abbreviations
CHKV: chikungunya virus; DENV: dengue fever virus; HA: harbourage area;
IRS: indoor residual spraying; SE: standard error; YFV: yellow fever virus;
ZIKV: Zika Virus
Acknowledgements
Thank you to Dr. Tobin Northfield at James Cook University for his advice
with the statistical analyses.
Funding
The study was funded by a Deployed Warfighter Deployment Grant (grant
#W911QY-15-1-0006) held by QIMR Berghofer. Dr. Scott A. Ritchie is supported
by the National Health and Medical Research Council. Senior Research
Fellowship #1044698.
Availability of data and materials
All data generated or analyzed during this study are included in this
published article.
Authors’ contributions
The experimental design was created by TB with some input from SR and
GD. All experiments were performed by TB. Data were recorded, analyzed,
and interpreted by TB. TB is the primary writer of this manuscript, with
significant intellectual input from SR and GD. SR and GD contributed
significantly to the editing of this manuscript. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Human ethics approval was granted by the James Cook University ethics
committee, H6286.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1College of Public Health, Medical and Veterinary Sciences, James Cook
University, PO Box 6811QLD, Cairns 4870, Australia. 2Mosquito Control
Laboratory, QIMR-Berghofer Medical Research Institute, QLD, Brisbane 4006,
Australia.
Received: 19 December 2016 Accepted: 25 May 2017
References
1. Scott TW, Chow E, Strickman D, Kittayapong P, Wirtz RA, Lorenz LH, et al.
Blood-feeding patterns of Aedes aegypti (Diptera, Culicidae) collected in a
rural Thai village. J Med Entomol. 1993;30(5):922–7.
2. Coffey LL, Failloux A-B, Weaver SC. Chikungunya virus-vector interactions.
Viruses. 2014;6:4628–63.
3. Scott TW, Clark GG, Lorenz LH, Amerasinghe PH, Reiter P, Edman JD.
Detection of multiple blood feeding in Aedes aegypti (Diptera, Culicidae)
during a single gonotrophic cycle using a histologic technique. J Med
Entomol. 1993;30(1):94–9.
4. Weaver SC. Arrival of Chikungunya virus in the New World: prospects for
spread and impact on public health. PLoS Negl Trop Dis. 2014;8(6):e2921.
5. All countries & territories with active Zika virus transmission. [https://
wwwnc.cdc.gov/travel/page/worldmap-areas-with-zika]. Accessed 15 Nov
2016.
6. WHO. Situation Report: Zika virus, microcephaly, Guillain-Barre syndrome
Edited by WHO: World Health Organization; 2016. p. 1–7.
7. Advice for people living in or travelling to South Florida. [https://www.cdc.
gov/zika/intheus/florida-update.html]. Accessed 15 Nov 2016.
8. Kearney M, Porter WP, Williams C, Ritchie S, Hoffmann AA. Integrating
biophysical models and evolutionary theory to predict climatic impacts on
Buhagiar et al. Parasites & Vectors  (2017) 10:270 Page 10 of 11
species’ ranges: the dengue mosquito Aedes aegypti in Australia. Funct Ecol.
2009;23:528–38.
9. Ritchie SA, Hanna JN, Hills SL, Piispanen JP, McBride WJH, Pyke AT, et al.
Dengue control in north Queensland, Australia: Case recognition and
selective indoor residual spraying. Dengue Bull. 2002;26:7–13.
10. Kay BH, Barker-Hudson P, Stallman ND, Wiemars MA, Marks EN, Holt PJ, et al.
Dengue fever - reappearance in northern Queensland after 26 years. Med J
Aust. 1984;140(5):264–8.
11. MacKenzie JS, La Brooy JT, Hueston L, Cunningham AL. Dengue in Australia.
J Med Microbiol. 1996;45(1996):159–61.
12. Notifiable conditions reports: Annual reporting. [https://www.health.qld.gov.
au/clinical-practice/guidelinesprocedures/diseases-infection/surveillance/
reports/notifiable/annual/default.asp]. Accessed 15 Nov 2016.
13. van den Hurk AF, Hall-Mendelin S, Pyke AT, Frentiu FD, McElroy K, Day A, et
al. Impact of Wolbachia on infection with chikungunya and yellow fever
viruses in the mosquito vector Aedes aegypti. PLoS One. 2012;6(11):e1892.
14. Moreira LA, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, Hedges LM, et al. A
Wolbachia symbiont in Aedes aegypti limits infection with dengue,
chikungunya, and Plasmodium. Cell. 2009;139(7):1268–78.
15. Aliota MT, Peinado SA, Velez ID, Osorio JE. The wMel strain of Wolbachia
reduces transmission of Zika virus by Aedes aegypti. Nature.
2016;6(28792):1–7.
16. Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH,
Muzzi F, et al. Successful establishment of Wolbachia in Aedes populations
to suppress dengue transmission. Nature. 2011;476(7361):454–7.
17. Miller B, Monath T, Tabachnick W, Ezike V. Epidemic yellow fever caused by
an incompetent mosquito vector. Trop Med Parasitol. 1989;40(4):396–9.
18. Bennett S: Queensland dengue management plan 2015–2020. Edited by
Health Q: Queensland Health; 2015.
19. Mosquito Control. [https://www.qld.gov.au/health/conditions/all/prevention/
mosquitoborne/control/index.html]. Accessed 15 Nov 2016.
20. Vazquez-Prokopec G, Montgomery BL, Horne P, Clennon J, Ritchie SA.
Combining contact tracing with targeted indoor residual spraying
significantly impacts dengue transmission. Sci Adv. 2017;3(2):e1602024.
21. Rapley LP, Russell RC, Montgomery BL, Ritchie SA. The effects of sustained
release metofluthrin on the biting, movement, and mortality of Aedes
aegypti in a domestic setting. Am J Trop Med Hyg. 2009;81(1):94–9.
22. Katsuda Y, Leemingsawat S, Thongrungkiat S, Prummonkol S, Samung Y,
Kanzaki T, et al. Control of mosquito vectors of tropical infectious diseases:
(3) Susceptibility of Aedes aegypti to pyrethroid and mosquito coils.
Southeast Asian J Trop Med Public Health. 2009;40(5):929–36.
23. Katsuda Y, Leemingsawat S, Thongrungkiat S, Komalamisara N, Kanzaki T,
Watanabe T, et al. Control of mosquito vectors of tropical infectious
diseases: (1) Bioefficacy of mosquito coils containing several pyrethroids and
a synergist. Southeast Asian J Trop Med Public Health. 2008;39(1):48–54.
24. Krieger RI, Dinoff TM, Zhang XF. Octachlorodipropyl ether (S-2) mosquito
coils are inadequately studied for residential use in Asia and illegal in the
United States. Environ Health Perspect. 2003;111(12):1439–42.
25. Liu W, Zhang J, Hashim JH, Jalaludin J, Hashim Z, Goldstein BD. Mosquito
coil emissions and health implications. Environ Health Perspect. 2003;
111(12):1454–60.
26. Hogarh J, Antwi-Agyei P, Obiri-Danso K. Application of mosquito repellent
coils and associated self-reported health issues in Ghana. Malar J. 2016;
15(61):1126–8.
27. Ujihara K, Mori T, Iwasaki T, Sugano M, Shono Y, Matsuo N. Metofluthrin: a
potent new synthetic pyrethroid with high vapor activity against
mosquitoes. Biosci Biotechnol Biochem. 2004;68(1):170–4.
28. Kawada H, Iwasaki T, Loan LL, Tien TK, Mai NTN, Shono Y, et al. Field
evaluation of spatial repellency of metofluthrin-impregnated latticework
plastic strips against Aedes aegypti (L.) and analysis of environmental factors
affecting its efficacy in My Tho City, Tien Giang, Vietnam. Am J Trop Med
Hyg. 2006;75(6):1153–7.
29. Kawada H, Maekawa Y, Takagi M. Field trial on the spatial repellency of
metofluthrin-impregnated plastic strips for mosquitoes in shelters without
walls (beruga) in Lombok, Indonesia. J Vector Ecol. 2005;30(2):181–5.
30. Lucas J, Shono Y, Iwasaki T, Ishiwatari T, Spero N, Benzon G. U.S. laboratory
and field trials of metofluthrin (SumiOne) emanators for reducing mosquito
biting outdoors. J Am Mosq Control Assoc. 2007;23(1):47–54.
31. Ritchie SA, Devine GJ. Confusion, knock-down and kill of Aedes aegypti
using metofluthrin in domestic settings: a powerful tool to prevent dengue
transmission? Parasit Vectors. 2013;6:262.
32. Darbro JM, Muzari MO, Giblin A, Adamczyk RM, Ritchie SA, Devine GJ.
Reducing biting rates of Aedes aegypti with metofluthrin: investigations in
time and space. Parasit Vectors. 2017;10:69.
33. Kawada H, Yen NT, Hoa NT, Sang TM, Dan NV, Takagi M. Field evaluation of
spatial repellency of metofluthrin impregnated plastic strips against
mosquitoes in Hai Phong city, Vietnam. Am J Trop Med Hyg. 2005;73(2):
350–3.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Buhagiar et al. Parasites & Vectors  (2017) 10:270 Page 11 of 11
